4 unknown. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
| Phase 2 | 4 | Unknown 4 |
Follow Shenzhen BinDeBio Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies CAR-T/TCR-T cells immunotherapy - Esophagus Cancer, Hepatoma | Phase 1 / Phase 2 | Unknown | Shenzhen BinDeBio Ltd. | 50 | 2019-09-01 | 2021-02-04 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies CAR-T cell immunotherapy - B-cell Acute Lymphoblastic Leukemia, Lymphoma | Phase 1 / Phase 2 | Unknown | Shenzhen BinDeBio Ltd. | 73 | 2018-03-01 | 2019-12-11 |
| A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects BinD19 - Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Unknown | Shenzhen BinDeBio Ltd. | 24 | 2017-03-02 | 2021-02-04 |
| A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects BinD19 - Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood | Phase 1 / Phase 2 | Unknown | Shenzhen BinDeBio Ltd. | 20 | 2016-11-01 | 2021-02-04 |
Burkitt Lymphoma (3) · Carcinoma, Hepatocellular (2) · Esophageal Neoplasms (2) · Glioma (2) · Stomach Neoplasms (2) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Leukemia, Myeloid (1) · Lung Neoplasms (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Melanoma (1) · Mesothelioma (1) · Multiple Myeloma (1) · Ovarian Neoplasms (1)
China (4)